Radioligand therapy (RLT) is an accurate oncological treatment that combines target molecules (ligands) with radioactive isotopes for the destruction of specific links and cancer cells to save healthy tissue. This is a targeted form of treatment for nuclear medicine cancer, offering new hope for patients with difficulty in treating tumors. The main objective of this market is to expan... https://www.metatechinsights.com/industry-insights/radioligand-therapy-market-2339